Recent Updates
  • The proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis

    Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise.

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/proteome-profiling-services.html
    The proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise. For more information please click on the following link: https://www.rootsanalysis.com/reports/proteome-profiling-services.html
    WWW.ROOTSANALYSIS.COM
    Roots Analysis
    Market research report on proteome profiling services with a focus on current market landscape and future growth opportunities
    0 Comments 0 Shares
  • The opportunity within the regulatory T-cell therapies market is projected to grow at an annualized rate of ~45%, till 2035, claims Roots Analysis

    Roots Analysis has done a detailed study on “Global Regulatory T-Cell (Tregs) Therapies Market”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

    For more information, please visit https://www.rootsanalysis.com/reports/regulatory-t-cell-therapies-market.html
    The opportunity within the regulatory T-cell therapies market is projected to grow at an annualized rate of ~45%, till 2035, claims Roots Analysis Roots Analysis has done a detailed study on “Global Regulatory T-Cell (Tregs) Therapies Market”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. For more information, please visit https://www.rootsanalysis.com/reports/regulatory-t-cell-therapies-market.html
    WWW.ROOTSANALYSIS.COM
    Roots Analysis
    Regulatory T-Cell Therapies Market report features an extensive study of the current market landscape and future potential of the...
    0 Comments 0 Shares
  • SINGLE-USE SENSORS FOR BIOPROCESSING MARKET– CURRENT AND FUTURE MARKET POTENTIAL

    Sensors are used to detect events or changes in environment parameters during a bioprocess control. These can be classified based on the type of variables measured, which include chemical variables (pH, dissolved oxygen or substrate or product concentration), physical variables (temperature, pressure, or viscosity), and biological variables (biomass concentration/morphology or biomass productivity).

    For additional details, please visit https://www.rootsanalysis.com/reports/single-use-sensors-for-bioprocessing.html
    SINGLE-USE SENSORS FOR BIOPROCESSING MARKET– CURRENT AND FUTURE MARKET POTENTIAL Sensors are used to detect events or changes in environment parameters during a bioprocess control. These can be classified based on the type of variables measured, which include chemical variables (pH, dissolved oxygen or substrate or product concentration), physical variables (temperature, pressure, or viscosity), and biological variables (biomass concentration/morphology or biomass productivity). For additional details, please visit https://www.rootsanalysis.com/reports/single-use-sensors-for-bioprocessing.html
    0 Comments 0 Shares
  • The single-use upstream bioprocessing technology market is projected to grow at a CAGR of 12% till 2035, claims Roots Analysis

    Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems.

    For more information, please click on the following link:
    https://www.rootsanalysis.com/reports/single-use-upstream-bioprocessing-technology-market.html
    The single-use upstream bioprocessing technology market is projected to grow at a CAGR of 12% till 2035, claims Roots Analysis Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems. For more information, please click on the following link: https://www.rootsanalysis.com/reports/single-use-upstream-bioprocessing-technology-market.html
    0 Comments 0 Shares
  • The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis

    Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance.

    For additional details, please visit https://www.rootsanalysis.com/reports/soft-tissue-sarcoma-market.html
    The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance. For additional details, please visit https://www.rootsanalysis.com/reports/soft-tissue-sarcoma-market.html
    Soft Tissue Sarcoma Market 2021-2031 | Industry Analysis | Market Size | 2030
    Soft Tissue Sarcoma Market report features an extensive study of the current landscape and the likely future potential of single-use system...
    0 Comments 0 Shares
  • With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

    With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism.

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/global-stem-cell-therapy-market-focus-on-cardiovascular-and-metabolic-disorders-2019-2030/246.html
    With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/global-stem-cell-therapy-market-focus-on-cardiovascular-and-metabolic-disorders-2019-2030/246.html
    WWW.ROOTSANALYSIS.COM
    Global Stem Cell Therapy Market: Focus on Cardiovascular and Metabolic Disorders, 2019-2030 | Industry Analysis | Market Size | 2030
    The stem cell therapies market for cardiovascular and metabolic disorders is poised to experience healthy growth at a CAGR of 10%+, over the coming decade
    0 Comments 0 Shares
  • The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis

    Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
    The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
    WWW.ROOTSANALYSIS.COM
    Subcutaneous Biologics Formulation Technologies and Drug Delivery Systems (4th Edition) Market | Industry Analysis | Market Size | 2030
    Market research report on subcutaneous biologics, technologies and drug delivery systems with focus on current market landscape and 2035 market size of...
    0 Comments 0 Shares
  • The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis

    Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
    The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit. For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
    WWW.ROOTSANALYSIS.COM
    Synthetic Lethality-based Drugs: Focus on DNA Repair (PARP Inhibitors) | Industry Analysis | Market Size | 2030
    Synthetic Lethality-based Drugs (DNA repair, parp inhibitors, brca gene mutation, pi3k inhibitor and others) Market is Poised to Witness a Rapid Growth
    0 Comments 0 Shares
  • The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis

    Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html
    The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html
    WWW.ROOTSANALYSIS.COM
    Targeted Protein Degradation Market | Industry Analysis | Market Size | 2030
    Research report on the future opportunity of targeted protein degradation therapeutics and technology platforms
    0 Comments 0 Shares
  • Telemedicine Tools and Software Providers Market

    The ability to remotely monitor patients using various consultation tools and software have revolutionized modern healthcare practices. The concept of monitoring patients over telephone can be traced back to the 1800’s. However, it was not until 1961, during the National Aeronautics and Space Administration (NASA) space mission, when remote physiologic monitoring of astronauts was efficiently required.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/telemedicine-tools-and-software-providers-market.html
    Telemedicine Tools and Software Providers Market The ability to remotely monitor patients using various consultation tools and software have revolutionized modern healthcare practices. The concept of monitoring patients over telephone can be traced back to the 1800’s. However, it was not until 1961, during the National Aeronautics and Space Administration (NASA) space mission, when remote physiologic monitoring of astronauts was efficiently required. For additional details, please visit https://www.rootsanalysis.com/reports/telemedicine-tools-and-software-providers-market.html
    WWW.ROOTSANALYSIS.COM
    Remote Patient Monitoring Market | Industry Analysis | Market Size | 2030
    Given their various benefits, the remote patient monitoring solution providers market is poised to grow at a CAGR of over 24.0%, till 2030...
    0 Comments 0 Shares
More Stories